LIFE, Low Insertion Force Epidural to Reduce Insertion Force

Information

  • Research Project
  • 7536987
  • ApplicationId
    7536987
  • Core Project Number
    R43GM085844
  • Full Project Number
    1R43GM085844-01
  • Serial Number
    85844
  • FOA Number
    PA-07-80
  • Sub Project Id
  • Project Start Date
    8/1/2008 - 16 years ago
  • Project End Date
    1/31/2009 - 15 years ago
  • Program Officer Name
    HEART, LUNG, AND BLOOD INST., NATIONAL
  • Budget Start Date
    8/1/2008 - 16 years ago
  • Budget End Date
    1/31/2009 - 15 years ago
  • Fiscal Year
    2008
  • Support Year
    1
  • Suffix
  • Award Notice Date
    7/28/2008 - 16 years ago

LIFE, Low Insertion Force Epidural to Reduce Insertion Force

[unreadable] DESCRIPTION (provided by applicant): This Phase I NIH SBIR, will design and demonstrate the Low Insertion Force Epidural (LIFE) insertion tool. Epidural anesthesia is a form of regional anesthesia involving injection of drugs directly into the epidural space and is used in 2.4 million births every year in the U.S. alone. A needle is placed within the epidural space, through which a catheter is usually passed. Local anesthetics are injected into the epidural space causing temporary loss of sensation and pain by blocking the transmission of pain signals through nerves in or near the spinal cord. The procedure can be unpleasant to the patient because of the high force levels required to penetrate the supraspinous ligament, interspinous ligament and ligamentum flavum. One of the most common complications is an accidental dural puncture. The epidural space is only a few [unreadable] [unreadable] millimeters deep and provides comparatively little resistance to the needle. A cerebrospinal fluid to leak into the epidural space results can cause a post dural puncture headache. Headaches can be severe and last from weeks to years. Significant leakage can cause enough intracranial hypotension as to tear veins causing a subdural hematoma, and can cause traction injuries to the cranial nerves resulting in tinnitus, hearing loss, dizziness, facial droop, or double vision. The LIFE device will enable the clinician a more controlled entry into the epidural space eliminating the over-shooting that often punctures the Dura accidentally from the current high force required. The device will utilize an innovative sharps motion control technology with lightweight, low-cost piezoelectric transducers. Phase I Specific Aims are: 1) Design and build a prototype LIFE epidural insertion tool, including piezoelectric elements and motion constraint to minimize heating that can reduce force required to penetrate muscle by 75% with less than 5[unreadable]C temperature rise. 2) Perform preliminary tests to optimize design for muscle penetration, balance, and ease of use, and build second-generation prototype. 3) Evaluate the LIFE concept prototype with clinical experts in regional anesthesiology to determine clinical value and approach for Phase II program. [unreadable] [unreadable] These aims will test the hypothesis that a commercially viable reduction in force tool can be developed to aid penetrating the ligamentum flavum for epidural insertion. [unreadable] [unreadable] The long-term objective of this work is to commercialize the catheter tool via a large medical OEM partner. Based on the numbers above, for the global market, roughly 5 million epidural kits are sold annually. The LIFE device should be able to take 10% of the market, due to ease of use and reduction of patient complications. PRII will develop and set up a manufacturing operation to produce the LIFE device. PUBLIC HEALTH RELEVANCE: Epidural anesthesia is used in 2.4 million births every year in the U.S. One of the most common complications is an accidental dural puncture. A cerebrospinal fluid to leak into the epidural space results, which can cause a post dural puncture headache and other painful complications. Development of low force epidural insertion tool will provide clinicians with a new technique to reduce the risk of dural puncture and other epidural complications. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    100000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:100000\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    PIEZO RESONANCE INNOVATIONS, INC.
  • Organization Department
  • Organization DUNS
    791379030
  • Organization City
    Bellefonte
  • Organization State
    PA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    16823
  • Organization District
    UNITED STATES